Scientists established a comprehensive molecularly and functionally characterized head and neck organoid biobank recapitulating the clinically relevant subtypes of TP53 mutant and human papillomavirus type 16 infection-driven head and neck cancer.
[Journal of Experimental & Clinical Cancer Research]